Robert Jones and oAgnes Hunt Orthopaedic Hospital NHS Foundation Trust

Oswestry, United Kingdom

Robert Jones and oAgnes Hunt Orthopaedic Hospital NHS Foundation Trust

Oswestry, United Kingdom
SEARCH FILTERS
Time filter
Source Type

Roberts S.,Robert Jones and oAgnes Hunt Orthopaedic Hospital NHS Foundation Trust | Roberts S.,Keele University | Evans H.,Robert Jones and oAgnes Hunt Orthopaedic Hospital NHS Foundation Trust | Wright K.,Robert Jones and oAgnes Hunt Orthopaedic Hospital NHS Foundation Trust | And 8 more authors.
Osteoarthritis and Cartilage | Year: 2015

Objective: To evaluate the potential of ADAMTS-4 (aggrecanase -1) activity in synovial fluid (SF) as a biomarker of knee injury and joint disease. Design: We have measured ADAMTS-4 activity in the synovial fluid of 170 orthopaedic patients with different degrees of joint pathology, using a commercial ADAMTS-4 fluorescence resonance energy transfer (FRET) substrate assay. Patients were classified at arthroscopy as (i) macroscopically normal, (ii) with an injury of the meniscus, anterior cruciate ligament or chondral/osteochondral defects or (iii) with osteoarthritis, and the influence of independent factors (age, patient group, effusion and synovial inflammation) on ADAMTS-4 activity levels was assessed. Results: In most patients (106/170) ADAMTS-4 activity was undetectable; ADAMTS-4 ranged from 0 to 2.8 ng/mL in synovial fluid from patients with an injury, 0-4.1 ng/mL in osteoarthritic patients and 4.0-12.3 ng/mL in patients with large effusions. Four independent variables each significantly influenced ADAMTS-4 activity in synovial fluid (all P < 0.001): age (concordance = 0.69), presence of osteoarthritis (OA) (concordance = 0.66), level of effusion (concordance = 0.78) and inflammation (concordance = 0.68). Not only did effusion influence the amount of ADAMTS-4 activity most strongly, but it also did this in an ordered manner (P < 0.001). Conclusions: The main finding of this study is that ADAMTS-4 levels in synovial fluid are most strongly correlated with inflammation and severity of effusion in the knee. Further study is required to determine if it could provide a useful tool to aid clinical diagnoses, indicate treatment, to monitor progression of joint degeneration or OA or alternatively the success of treatment. © 2015 The Authors.

Loading Robert Jones and oAgnes Hunt Orthopaedic Hospital NHS Foundation Trust collaborators
Loading Robert Jones and oAgnes Hunt Orthopaedic Hospital NHS Foundation Trust collaborators